Roivant Sciences GmbH
5Patents
5Active
5Granted
46Portfolio score
Filing activity: Jul 10, 2017 → Apr 16, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10045988B2 | Spirocyclic compounds as tryptophan hydroxylase inhibitors | Emerging Cross-Sectional Technologies | 8 | Active |
| US10350208B2 | Spirocyclic compounds as tryptophan hydroxylase inhibitors | Emerging Cross-Sectional Technologies | 6 | Active |
| US10946018B2 | Spirocyclic compounds as tryptophan hydroxylase inhibitors | Emerging Cross-Sectional Technologies | 5 | Active |
| US10660893B2 | Spirocyclic compounds as tryptophan hydroxylase inhibitors | Emerging Cross-Sectional Technologies | 5 | Active |
| US10710948B2 | Processes for preparing (R)-1-(5-chloro-[1,1″-biphenyl] -2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1″-biphenyl]-2-yl)-2,2,2-trifluoroethanone | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.